Visionflex Strengthens Financial Position with Positive Cash Flow and New Contract Wins
Visionflex Group Limited (ASX: VFX) delivered a solid June 2026 quarter, achieving positive operating cash flow of AU$0.7 million and maintaining positive cash generation throughout the second half of FY26. The result reflects improved cost discipline and stronger operating efficiency, while customer cash receipts increased to AU$2.1 million for the quarter and AU$4.9 million for the full year. Although reported revenue softened due to customer-requested delays in hardware deliveries, the underlying orders remain secured and are expected to contribute to FY27 results. During the quarter, the company expanded its customer base through new agreements with healthcare providers, aged care organisations and commercial clients. Visionflex also launched its unattended access technology, allowing clinicians to perform remote consultations without requiring support staff at the patient location, broadening the platform's potential applications. Backed by AU$1.62 million in cash and additional available funding, the company is well positioned to pursue enterprise growth, expand recurring revenue and support future product innovation.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Visionflex Strengthens Financial Position with Positive Cash Flow and New Contract Wins
Visionflex Group Limited (ASX: VFX) delivered a solid June 2026 quarter, achieving positive operating cash flow of AU$0.7 million and maintaining positive cash generation throughout the second half of FY26. The result reflects improved cost discipline and stronger operating efficiency, while customer cash receipts increased to AU$2.1 million for the quarter and AU$4.9 million for the full year. Although reported revenue softened due to customer-requested delays in hardware deliveries, the underlying orders remain secured and are expected to contribute to FY27 results. During the quarter, the company expanded its customer base through new agreements with healthcare providers, aged care organisations and commercial clients. Visionflex also launched its unattended access technology, allowing clinicians to perform remote consultations without requiring support staff at the patient location, broadening the platform's potential applications. Backed by AU$1.62 million in cash and additional available funding, the company is well positioned to pursue enterprise growth, expand recurring revenue and support future product innovation.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au